Tele-epilepsy Market Will See Strong Expansion Through 2030: Grand View Research Inc.

 Tele-epilepsy Market Growth & Trends

The global tele-epilepsy market size is expected to reach USD 1.16 billion by 2030, based on a new report by Grand View Research, Inc. The industry for tele-epilepsy is expected to expand at a CAGR of 15.7% from 2022 to 2030, aided by the rising adult population suffering from epilepsy, and increased investments in the healthcare telemedicine ecosystem by governments and private players globally.

The COVID-19 pandemic had a positive impact on the tele-epilepsy industry. The outbreak severely impacted the healthcare system and the economy, which created a special barrier for individuals seeking medical care, including epilepsy care. In addition, telehealth initiatives have demonstrated a high level of patient and physician satisfaction and quality during COVID-19. It has been seen that providing complex epilepsy care, including to patients with severity in epilepsy, could be solved, and can produce results that are comparable to those of in-person consultations.

Tele-epilepsy Market Report Scope

Report Attribute	Details
Market size value in 2022	USD 0.36 billion
Revenue forecast in 2030	USD 1.16 billion
Growth rate	CAGR of 15.7% from 2022 to 2030
Base year for estimation	2021
Actual estimates/Historic data	2017 - 2020
Forecast period	2022 - 2030

Governments worldwide are initiating programs to uplift the market for tele-epilepsy. For instance, several government entities are embracing telehealth by implementing new regulations and reimbursement standards. In March 2020, The Federal Communications Commission in the US developed initiatives to aid healthcare organizations in implementing telemedicine technology.

Request a free sample copy or view report summary: Tele-Epilepsy Market Report

Tele-epilepsy Market Report Highlights

• Based on the patient market, the adult segment held the highest revenue share in 2021 and is expected to expand at a CAGR of 15.8% during the forecast period, owing to an increase in the number of adult patients prone to epilepsy
• Based on component, the hardware segment dominated the market in terms of revenue with a share of 41.2% in 2021, owing to the increasing hardware requirements such as videoconferencing technology, audio equipment, microphones, screens, and other medical accessories to support virtual visits
• In terms of end-use, the hospital segment accounted for a substantial revenue share of 34.2% in the market in 2021 and is expected to expand at a steady CAGR through 2030, as hospitals are preferred by patients for their treatment process in the context of convenience and variety of product offerings in one place
• In 2021, North America dominated the tele-epilepsy market with a revenue share of 37.9%, owing to its highly developed and technologically advanced infrastructure, a rise in the number of cases of epilepsy, and increasing per capita income in the region
• Asia Pacific is anticipated to advance at the fastest CAGR of 16.6% during the projection period. The increasing incidences of epilepsy and the growing population, along with rapidly evolving healthcare infrastructure and government policies, can be attributed to the regional market growth

Access Press Release@ https://www.grandviewresearch.com/press-release/global-tele-epilepsy-market

Tele-epilepsy Market Segmentation

Grand View Research has segmented the global tele-epilepsy market based on patient market, component, end-use, and region:

Tele-epilepsy Patient Market Outlook (Revenue, USD Million, 2017 - 2030)

• Pediatric
• Adult

Tele-epilepsy Component Outlook (Revenue, USD Million, 2017 - 2030)

• Hardware
• Software
• Service

Tele-epilepsy End-use Outlook (Revenue, USD Million, 2017 - 2030)

• Hospitals
• Payers
• Healthcare consumers

Tele-epilepsy Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in the Tele-epilepsy Market

• Shimmer
• Empatica
• SOC Telemed
• Eagle Telemedicine
• Sevaro
• Tele Specialists
• Chiron Health
• RTTC
• Science Soft USA Corporation
• Vidyo, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.S. Home Infusion Therapy Market Report By Opportunity, Demand, Recent Trends, Major Driving Factors and Business Growth Strategies

 U.S. Home Infusion Therapy Market Growth & Trends

The U.S. home infusion therapy market size is expected to reach USD 31.8 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 7.5% from 2022 to 2030. The growing geriatric population and increasing prevalence of disorders, such as cancer, immune deficiencies, Crohn's disease, infections, dehydration, nutritional deficiencies, multiple sclerosis, nausea, and vomiting are majorly driving the market’s growth. The increasing need for reduced hospital stays and the rising prevalence of chronic disorders in the geriatric population are driving the growth.

Growing cases of Hospital Acquired Infections (HAI) is another major factor driving the growth of the U.S. home infusion therapy industry over the forecast period. According to the U.S. Centers for Disease Control and Prevention, approximately 1.7 million admitted patients are affected annually by Healthcare Acquired infections (HCAIs) and around 98, 000 patients (1 in 17 patients) die due to the same. Due to this, the demand for home infusion therapy is increasing substantially.

Increasing innovations in home infusion therapy such as the incorporation of electronic healthcare records along with medical devices and infusion pumps are trending. It allows storage, retrieval, and alteration of medical records, making it easier for healthcare professionals and patients to track the improvements in a particular disorder.

Increasing patients’ preference for home healthcare since it is cost-efficient in comparison with hospital stays is an opportunity for the industry players to launch more innovative products. Also, the introduction of safety products will ultimately help the growth of the U.S. home infusion therapy market. The advent of COVID-19 boosted the home infusion market in the country as many key players like Baxter, BD, ICU Medical, and Option Care Health, Inc reported revenue increases for their home infusion products and services in 2020 and 2021. This trend is expected to further boost the market as numerous healthcare settings in the country are expected to permanently opt for home infusion services to decrease patient admission burden in hospitals and other healthcare facilities

Request a free sample copy or view the report summary: U.S. Home Infusion Therapy Market Report

U.S. Home Infusion Therapy Market Report Highlights

• The infusion pumps segment held the largest revenue share compared to others due to the increasing use and efficiency in delivering required quantities of nutrition, medications, and other essential fluids
• The needleless connectors segment is expected to witness the fastest growth owing to various benefits, such as less risk of bacterial contamination and higher protection against needle stick injuries
• The anti-infective segment held the maximum revenue share in 2021 owing to its extensive use as an antifungal, antibiotic, and antiviral agent at home care
• Endocrinology is predicted to be the fastest-growing segment owing to the growing number of conditions associated with the endocrine system, such as thyroid and diabetes

Access Press Release@ https://www.grandviewresearch.com/press-release/us-home-infusion-therapy-market-analysis

U.S. Home Infusion Therapy Market Segmentation

Grand View Research has segmented the U.S. home infusion therapy market based on product and application:

U.S. Home Infusion Therapy Product Outlook (Revenue, USD Million, 2018 - 2030)

• Infusion pumps
  • Elastomeric
  • Electromechanical
  • Gravity
  • Others
• Intravenous Sets
• IV Cannulas
• Needleless Connectors

U.S. Home Infusion Therapy Application Outlook (Revenue, USD Million, 2018 - 2030)

• Anti-Infective
• Endocrinology
  • Diabetes
  • Others
• Hydration Therapy
  • Athletes
  • Others
• Chemotherapy
• Enteral Nutrition
• Parenteral Nutrition
• Specialty Pharmaceuticals
• Others

List of Key Players in U.S. Home Infusion Therapy Market

• Braun Melsungen,
• Baxter International,
• Caesarea Medical Electronics Ltd.,
• CareFusion,
• Fresenius Kabi,
• ICU Medical,
• JMS CO., LTD.,
• Smiths Medical, Inc.,
• Terumo Corporation,
• Coram LLC,
• Option Care Enterprises, Inc.,
• BioScrip, Inc.,
• BriovaRx Infusion Services,
• Paragon Healthcare

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cognitive Assessment And Training In Healthcare Market to Witness a Pronounce Growth During 2022 – 2030: Grand View Research Inc.

 Cognitive Assessment & Training in Healthcare Market Growth & Trends

The global cognitive assessment and training in healthcare market size is expected to reach USD 26.4 billion by 2030, expanding at a CAGR of 25.5% from 2022 to 2030, according to a new report by Grand View Research, Inc. Healthcare professionals use cognitive assessment to evaluate patients who exhibit loss of memory or other signs of cognitive impairment. These assessments are helpful in screening for a variety of illnesses including Parkinson's disease, brain tumors, and stroke-related cognitive problems, and identifying patients who are at risk of developing dementia. The rise in incidence rates of dementia cases, increasing awareness regarding cognitive health, and technologically advanced cognitive assessments & training tools remain key factors for growth. Moreover, increased application of cognitive assessments in clinical trials and dementia research are also other factors driving the growth of the market.

The COVID-19 pandemic affected the market with a reduction in emergency visits and significantly delayed outpatient clinic appointments. In addition, consultation services that involve one-on-one interaction were hampered due to concerns about transmission. The market players suffered losses in the initial phase. However, telemedicine and online platforms for cognitive testing and training created new revenue streams to mitigate some of those losses. As a result, cutting-edge technologies such as remote (decentralized) clinical trials and home-based assessments have been adopted at an unprecedented rate.

The demand for brain assessment training by the tech-savvy generation and the expanding market for cognitive solutions are both driving the rise of the cognitive assessment and training sector. Due to the advancement of technology, brain training activities have been steadily incorporated into computerized training on smartphones and tablets, computers, and more recently, gaming consoles. Some brain training regimens focus on particular cognitive skills, while others are more comprehensive and interconnected. Programs for cognitive training may include manipulatives; additional support, such as playing cards; physical activity; tasks requiring paper and pencil; computer-based exercises; and other training techniques.

Request a free sample copy or view the report summary: Cognitive Assessment And Training In Healthcare Market Report

Cognitive Assessment And Training In Healthcare Market Report Highlights

• Based on the assessment, the pen and paper assessment segment dominated the market with a revenue share of 47.7% in 2021, owing to easier availability, convenience, and affordability. The hosted assessment segment is expected to witness a CAGR of over 26% over the forecast period pertaining to the increased adoption of telemedicine
• Based on component, the services segment held a majority of the revenue share of 59.3% in 2021 owing to the increasing demand for training & support and consulting for rater qualification, training, and management that equip raters to administer scales in the most efficient manner while adhering to the highest standards
• Based on application, the clinical trials segment dominated the market with a revenue share of 41.0% in 2021 and is expected to retain its position during the forecast period
• North America held the largest revenue share of 37.9% in 2021 owing to the rising public awareness related to the treatments of cognitive illnesses. Due to the rapidly aging population in the region, which is susceptible to cognitive disorders, government funding for clinical trials and research has increased
• Asia Pacific is expected to witness the fastest CAGR of 26.5% over the forecast period from 2022 to 2030, due to increasing incidence of sports injuries & trauma leading to cognitive impairment, rising geriatric population, rapidly expanding healthcare infrastructure, and growing government backing

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cognitive-assessment-training-healthcare-market

Cognitive Assessment And Training In Healthcare Market Segmentation

Grand View Research has segmented the global cognitive assessment and training in healthcare market based on assessment, component, application, and region:

Cognitive Assessment And Training In Healthcare Assessment Outlook (Revenue, USD Million, 2017 - 2030)

• Biometrics Assessment
• Pen and Paper Based-Assessment
• Hosted Assessment

Cognitive Assessment And Training In Healthcare Component Outlook (Revenue, USD Million, 2017 - 2030)

• Solution
  • Assessment
  • Data Analysis & Reporting
  • Data Management
  • Others
• Services
  • Training & Support
  • Consulting

Cognitive Assessment And Training In Healthcare Application Outlook (Revenue, USD Million, 2017 - 2030)

• Clinical Trials
• Screening & Diagnostics
• Brain Training
• Academic Research

Cognitive Assessment And Training In Healthcare Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Cognitive Assessment And Training in Healthcare Market

• Cambridge Cognition Ltd
• CogniFit Inc
• Cogstate Ltd
• CNS Vital Signs, LLC
• Brain Resource Company
• WIRB-Copernicus Group
• Quest Diagnostics Incorporated
• Signant Health
• Posit Science
• Clario
• Cognetivity Neurosciences

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

U.K. Ambulatory Services Market is Expected to Enhance $249.1 Billion Revenue By 2030: Grand View Research Inc.

 U.K. Ambulatory Services Market Growth & Trends

The U.K. ambulatory services market value is estimated to reach USD 249.1 billion by 2030, based on the latest report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.30% from 2023 to 2030. The growing burden on hospitals in the U.K., the rising geriatric population, increasing healthcare expenditure, and the growth in government initiatives to promote ambulatory care are key factors driving the market.

More than 10 billion surgeries are performed in England every year. The increasing requirement for surgery is increasing the waiting time for patients in the hospital, resulting in an increasing preference for outpatient care. The adoption of technology & improving quality care has led to a high percentage of ophthalmic, orthopedic, and cosmetic surgeries being performed in ambulatory facilities. For Instance, as per Health at Glance 2021: OECD indicators, around 99.1% of cataract surgeries performed in the U.K. were ambulatory cases.

Outpatient facilities in the U.K. are well-regulated. The Care Quality Commission (CQC) licenses healthcare providers monitors & supervises them. This institution establishes the legal standards for providers such as hospitals, ambulatory care centers, and offices. All healthcare providers (including organizations, specialty cooperatives, and individual providers) are required to register with the CQC, and their performance should be reviewed in accordance with the national quality standards. The establishment of proper regulations ensures quality care at ambulatory facilities, thereby increasing the market demand. However, for the new players, the high-quality regulations are making it difficult for them to sustain. The operation costs for the market players have increased overall as a result of regulatory requirements.

Request a free sample copy or view report summary: U.K. Ambulatory Services Market Report

U.K. Ambulatory Services Market Report Highlights

• The primary care offices held the largest market share in 2021, as they are the first contact point between healthcare professionals and patients. Primary care is delivered in the form of in-person clinic consultations and home visits for patients unable to travel. Home visits are witnessing high demand post the COVID-19 pandemic.
• During the forecast period, the surgical specialty segment is estimated to witness the fastest growth as hospitals are starting separate same-day surgery centers. Furthermore, due to the reimbursement advantages for ambulatory surgical centers, the number of hospital acquisitions of ambulatory surgical centers is increasing.
• The adoption of ambulatory Electronic Health Records(EHRs) and telehealth consultations is expected to decrease the treatment time for patients.
• Hospital chains are collaborating with physicians for initiating outpatient services to reduce the burden of cost and increase their revenue. The hospitals are starting their own ambulatory unit, for competing against the freestanding service providers.
• In response to the COVID-19 pandemic, the government’s focus on outpatient care has increased. The British Association for Ambulatory Emergency Care (BAAEC) introduced guidelines for emergency care. The BAAEC suggested providing ambulatory care services closely located to emergency departments and their initiatives are aimed at maximizing the patient flow to ambulatory care to reduce the burden on hospitals

Access Press Release@ https://www.grandviewresearch.com/press-release/uk-ambulatory-services-market-analysis

U.K. Ambulatory Services Market Segmentation

Grand View Research has segmented the U.K. ambulatory services market based on type:

U.K. Ambulatory Services Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Primary Care Offices
• Outpatient Departments
• Emergency Departments
• Surgical Specialty
  • Orthopedics
  • Ophthalmology
  • Gastroenterology
  • Pain Management
  • Plastic Surgery
  • Others
• Medical Specialty

List of Key Players in the U.K. Ambulatory Services Market

• Guy's and St Thomas' NHS FT
• Aspen Healthcare
• BHR University Hospitals NHS Trust
• Chelsea and Westminster Hospital NHS FT
• Brighton and Sussex University Hospitals NHS FT
• OneWelbeck
• The Queen Elizabeth Hospital King's Lynn NHS FT
• HCA Healthcare U.K.
• Nottingham University Hospitals NHS FT
• Milton Keynes NHS FT

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Companion Robots Market Latest Innovations, Drivers and Industry Key Events 2023– 2030: Grand View Research Inc.

 Healthcare Companion Robots Market Growth & Trends

The global healthcare companion robots market is expected to reach USD 5.6 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 17.8% for the forecast period 2023-2030. Companion robots are created with a purpose of offering a companionship to humans. These robots assist people especially elderly population in their daily activities and helps to improve their lives.

With increasing geriatric population and rising prevalence of diseases such as Alzheimer’s; dementia, etc., the demand of companion robots is likely to increase over a forecast period. Various robots are being developed which help people suffering from such disorders to live normal life. For instance, Ryan, a companion robot outfitted with artificial intelligence technology is designed to assist the aging population, specifically those struggling with Alzheimer’s. Also, it is equipped with cognitive games to keep the brain active and helps recognize who it interacts with and carry on conversations. In addition, the increasing incidences of depression is fueling market growth. Furthermore, with the outbreak of COVID-19, the prevalence of loneliness raised, which positively impacted the demand for companion robot. Paro, a companion robot approved by the FDA as an insured cost for patients is used to assist people with depression, anxiety, and other conditions. These robo-seals are provided in free to licensed nursing homes and in around 28 nursing homes in Washington State have started using them since last year.

In addition, various initiatives undertaken by market players to provide innovative solutions is anticipated to drive the growth of the market during the forecast period. For instance, in March 2022, Intuition Robotics launched ElliQ, a digital care companion. It is designed to help older adults to be more physically active and socially engaged and enable them to have happier, more independent lives. Furthermore, integration of advanced technologies to improve the healthcare outcome is expected to boost the market in upcoming years.

Request a free sample copy or view report summary: Healthcare Companion Robots Market Report

Healthcare Companion Robots Market Report Highlights

• In 2022, the humanoid segment held the largest share due to its increasing demand in medical procedures to keep children distracted and its use in autism special education.
• The geriatric segment dominated the healthcare companion market in 2022 due to the rising use of these robots to assist the elderly population and help them to mitigate the depression and anxiety issues
• Asia pacific held the largest share in 2022 due to higher adoption of these robots in countries like japan and various initiatives undertaken for the deployment of robots in the region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-healthcare-companion-robots-market

Healthcare Companion Robots Market Segmentation

Grand View Research, Inc. has segmented the healthcare companion robots market report based on type, age-group and region.

Healthcare Companion Robots Type Outlook (Revenue, USD Million, 2017 - 2030)

• Animal-like
• Humanoid

Healthcare Companion Robots Age-group Outlook (Revenue, USD Million, 2017 - 2030)

• Children
• Adult
• Geriatric

Healthcare Companion Robots Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Healthcare Companion Robots Market

• Blue Frog Robotics & Buddy
• ASUS
• Intuition Robotics
• inGen Dynamics
• PARO Robots U.S., Inc.
• No Isolation
• Luvozo
• Honda Robotics
• Hanson Robotics
• Ubtech
• Emotix
• Jibo

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cyclopentane Market Poised to Expand at a Robust Pace Over 2030: Grand View Research Inc.

 Cyclopentane Market Growth & Trends

The global cyclopentane market size is anticipated to reach USD 675.7 million by 2030, expanding at a robust CAGR of 7.3% over the forecast period, according to a new report by Grand View Research, Inc. An increase in demand for refrigerators across various sectors is expected to propel the market growth.

The COVID-19 pandemic negatively impacted the market as production activities were halted worldwide. The outbreak of the pandemic caused widespread disruption in supply chains leading to a shortage of raw materials and inflated costs across the board. But since the hydrochlorofluorocarbons (HCFCs) phasing out regulation by Montreal Protocol, it has propelled the demand for cyclopentane in applications such as refrigerators and insulating products. It also eliminated substances producing carbon emissions providing a more green alternative for the future. These factors led to a strong recovery in the cyclopentane industry.

The recent Russia-Ukraine war also led to inflated crude oil prices which affected the growth of the cyclopentane industry. However, owing to the rising demand for insulated products, the market is set to witness growth over the forecast period.

Request a free sample copy or view report summary: Cyclopentane Market Report

Cyclopentane Market Report Highlights

• Based on function, the blowing agent & refrigerant segment accounted for the largest revenue share of 62.6% in 2021 and is expected to retain its dominance over the forecast period owing to its increased use in the automotive, construction, electrical, and appliance industries. The solvent & reagent segment is expected to grow at a CAGR of 7.1% over the forecast period
• Based on application, the refrigerators segment is expected to dominate the market over the forecast period owing to the rise in per capita income and demand for packaged & frozen food and medicines. The containers & sippers segment is likely to grow at a CAGR of 8.3% over the forecast period
• Asia Pacific held a market share of 37.2% in 2021 and is expected to dominate the segment over the forecast period. Europe is anticipated to expand at a CAGR of 7.0% over the forecast period. The growth is primarily attributed to the rising demand for insulating materials in the construction industry, refrigerators, and other insulation applications
• In September 2022, Haltermann Carless, HCS Group’s brand, inaugurated its new hydrogenation unit in Germany to solidify its position as a leading manufacturer of cyclopentane, as well as to expand its business areas through the Speyer site. It plans to increase production by 70% by the first quarter of 2023
• Mergers & acquisitions, agreements, R&D activities, and expansions are the key strategies adopted by the companies over the past years. For instance, in June 2022, Chevron Phillips LLC expanded its operations in Europe by setting up a polyalphaolefins (PAOs) production unit in Belgium to cater to the growing demand. The investment at the Beringen plant will help the company double its PAO production by 2024. Sustainability and environment-friendly material usage being the key moving ahead, it is also a crucial factor that will drive the market growth over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cyclopentane-market

Cyclopentane Market Segmentation

Grand View Research has segmented the global cyclopentane market based on function, application, and region:

Cyclopentane Function Outlook (Volume, Tons; Revenue, USD Million, 2017 - 2030)

• Blowing Agent & Refrigerant
• Solvent & Reagent
• Others

Cyclopentane Application Outlook (Volume, Tons; Revenue, USD Million, 2017– 2030)

• Refrigerators
• Containers & Sippers
• Personal Care Products
• Electrical & Electronics
• Insulating Construction Material
• Fuel & Fuel Additives
• Others

Cyclopentane Regional Outlook (Volume, Tons; Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players in the Cyclopentane Market

• HCS Group GmbH
• Dymatic Chemicals, Inc
• Chevron Phillips Chemical Company
• SK geo centric Co. Ltd
• LG Chem
• Maruzen Petrochemical
• Liaoning Yufeng Chemical Co, Ltd
• Haldia Petrochemicals Limited
• YEOCHUN NCC CO. LTD
• SOUTH HAMPTON RESOURCES
• ZEON CORPORATION
• Puyang Zhongwei Fine Chemical Co. Ltd

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sunglasses Market Get Facts About Business Strategies 2022 to 2030: Grand View Research Inc.

 Sunglasses Market Growth & Trends

The global sunglasses market size is expected to reach USD 48.19 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.1% from 2022 to 2030. The key drivers of the market include advanced and improved products and services that meet specific client needs. Additionally, increasing consumer inclination toward well-designed and quality products to increase their outfit and style has increased the demand for sunglasses. Customers are more expected to buy new products than old ones. Manufacturers' advanced breakthroughs have allowed them to present sunglasses with extra utility. Counterfeit products negatively impact the sales and pricing strategies of major players' offerings, thus hampering the growth of the market.

The COVID-19 pandemic had a negative impact on the market. The COVID-19 pandemic affected manufacturing activities and disrupted the distribution network of the market internationally. The government’s strict limitations and guidelines regarding social distancing and complete lockdowns had led to huge losses for the companies operating in the market. All the major brand outlets and other sales channels were closed for the lockdown period. The future of the market depends on the digitization of the supply chains in the sunglasses industry all over the world.

Non-polarized sunglasses accounted for the largest share of over 70.0% in 2021. This is due to their effectiveness in different environmental conditions. Consumers buy sunglasses owing to their fashion proportion, and polarization is only a relevant criterion for individuals that need targeted usage, such as for cycling. It is a popular choice for customers globally owing to its easy accessibility in both offline and online channels.

Europe dominated the global market and held a share of over 35.0% in 2021. This is attributed to the presence of leading industry players and the high disposable income of buyers in the region. An increase in awareness regarding unsafe UV beams among buyers is a key factor that is credited to the popularity in the region. The large percentage of spectacle wearers, along with booming retail prices of frames, will drive the market in this region.

Key players operating in the market are focused on offering high-quality sunglasses in new frame styles as well as lens colors to attract customers. For instance, MaumiJi, Inc. offers polarized reading sunglasses that are manufactured using bifocal lenses and are specially designed to read in intense sunlight.

Request a free sample copy or view the report summary: Sunglasses Market Report

Sunglasses Market Report Highlights

• Asia Pacific is expected to witness the fastest growth from 2022 to 2030. This is attributed to the growing standard of living and changes in lifestyle in countries such as India, Japan, and South Korea
• The polarized segment is likely to witness the fastest growth from 2022 to 2030. This is attributed to the high participation in outdoor sports and activities such as skiing and hiking all over the world
• The online distribution channel segment is expected to expand at the fastest CAGR from 2022 to 2030. This is attributed to the reasonable prices and plenty of choices that it gives to the customers. Additionally, the choice of trial before buying that is offered by online retailers is another important factor expected to drive the segment over the forecast period

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sunglasses-market

Sunglasses Market Segmentation

Grand View Research has segmented the global sunglasses market based on product, distribution channel, and region:

Sunglasses Product Outlook (Revenue, USD Million, 2017 - 2030)

• Polarized
• Non-polarized

Sunglasses Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Offline
• Online

Sunglasses Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Central & South America
  • Brazil
• Middle East & Africa
  • UAE

List of Key Players in Sunglasses Market

• Luxottica Group
• Safilo Group
• Maui Jim
• De Rigo
• Charmant
• Specsavers Optical
• Revo
• Fielmann AG
• Pivothead
• LVMH Group
• MarcolinSpA

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sneakers Market Outlook Growth Emerging Factors On Geography, Technological Advancements And Mounting Demand Forecast To 2022-2030

 Sneakers Market Growth & Trends

The global sneakers market size is expected to reach USD 128.34 billion by 2030, registering a CAGR of 5.2% from 2022 to 2030, according to a new report by Grand View Research, Inc. The advent of 3D printing on sneakers and the growing penetration of the internet & smartphones are leading to an increase in the inclination toward online medium as it offers the flexibility to choose, which, in turn, is further increasing the growth of the global market. In addition, the increased population, changing fashion trends, and penetration of the internet & smartphones drive the market. However, the availability of counterfeit products may hamper the growth.

The COVID-19 pandemic has had a negative impact on the industry. The short-term shutdown of factories and interruption in the new collection release were the key factors that affected the growth. Manufacturing plants were shut and production in China disturbed the supply chain of raw materials, thereby impacting the global industry in 2020. The impact of the pandemic has also pushed back certain release dates as a handful of coveted Jordans that were set to drop in March marked their way to Nike.com, SNKRS, and other places at a later date. Moreover, Adidas AG and Puma Inc. reported drastic losses in their revenues in 2020.

The online segment is likely to register the fastest CAGR during the forecast period. Online buying permits customers to find a variety of sneakers that are not available in a physical store. There are so many more options to choose from at online shops. The users can simply browse through numerous brands. The development of this industry will have to keep up with customer preferences as they demand more comfort as well as convince in online shopping. Asia Pacific accounted for the largest revenue share in 2021. China was the major country in the region in terms of share.

Rapid urbanization and the rise in middle-class consumers in emerging as well as developed nations have encouraged the adoption of convenience-oriented lifestyles, making sneakers more desirable for consumers of almost all age groups. Major players face solid competition from each other, as some of them work at several locations and have a loyal customer base. In addition, companies are concentrating on building customer relationships through a customer service network and are expanding internationally. They are also launching new designs through constant innovation, which will further intensify market competition.

Request a free sample copy or view the report summary: Sneakers Market Report

Sneakers Market Report Highlights

• North America is expected to register the fastest CAGR over the forecast period due to increasing product demand among the young generation
• The mid-top sneakers segment is likely to register the fastest growth rate during the forecast period
• This is owing to the high demand for mid-top products due to the benefits, such as low weight and better cut
• The department store distribution channel segment generated the maximum sales in 2021 as these stores have advantages, such as festive and seasonal offers, lower prices, discounted rates, and big displays with freedom of selection
• The women segment is likely to record the highest CAGR from 2022 to 2030 due to the easy availability of a vast range of sneakers that are designed specifically for women

Access Press Release@ https://www.grandviewresearch.com/press-release/global-sneakers-market

Sneakers Market Segmentation

Grand View Research has segmented the global sneakers market based on product type, end-user, distribution channel, and region:

Sneakers Product Type Outlook (Revenue, USD Million, 2017 - 2030)

• Low-Top Sneakers
• Mid-Top Sneakers
• High-Top Sneakers

Sneakers End-user Outlook (Revenue, USD Million, 2017 - 2030)

• Men
• Women
• Kids

Sneakers Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

• Department Store
• Specialty Stores
• Online
• Others

Sneakers Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • France
• Asia Pacific
  • China
  • India
  • Japan
• Central & South America
  • Brazil
• Middle East & Africa
  • South Africa

List of Key Players in Sneakers Market

• Nike Inc.
• Adidas AG
• New Balance Athletics, Inc.
• ASICS Corp.
• Kering SA
• Skechers USA, Inc.
• Under Armour Inc.
• VF Corp.
• Puma SE
• Relaxo Footwears Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Biomimetics Market to Expand with Significant CAGR During 2022 – 2030: Grand View Research Inc.

 Medical Biomimetics Market Growth & Trends

The global medical biomimetics market size is expected to reach USD 52.2 billion by 2030, registering a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Growing advancement in nanotechnology, increasing demand for prostheses and implant, rise in R&D activities associated with medical biomimetics and strategic activities by key market players are the major factors which are likely to drive the market growth. For instance, in April 2021, curasan AG expanded its distribution network in Europe, the company has added Silesia Dental and Implants Diffusion International SARL to its European distribution network.

Diseases affecting the cornea are most important cause of blindness across the globe. According to the WHO, around 2 million new cases of corneal blindness are reported every year. More than 30 million people across the globe are blind in one or both eyes from corneal disease and injury, while several suffer from degraded visual acuity. Numerous attempts to create reliable, robust, and scalable solutions for artificial cornea have been unsuccessful. As such, there exists an unmet need, the research and development activities are being carried out for affordable and long-lasting solutions for pathology, injury, and corneal blindness. For instance, in March 2022, researchers from the Centre for LV Prasad Eye Institute, IIT-Hyderabad and Cellular, and Molecular Biology developed an exclusive biomimetic corneal hydrogel, manufactured from discarded human corneas, which can be used for the treatment of corneal scarring, the main cause of corneal blindness.

Numerous companies in the medical biomimetics market are expanding their products in emerging markets. For instance, a most important new development, in November 2021, Osteopore has been granted a patent in China for its smart 3D biometric scaffolds. The technology was developed with scientists from NTU Singapore and was previously granted a European patent in early 2021. This patent is anticipated to create numerous research and development opportunities in the Chinese market and allows the company to tap into local expertise as part of its product advancement process.

The COVID-19 pandemic is anticipated to negatively impact the medical biomimetics market growth. The COVID-19 pandemic had a considerable effect on the number of patients looking for dental treatments. The overall reduction in the number of patients treated in the Hospitals in Jordan was about 90.4% (17,591 to 1689). As a result, the usage of these technologies was less during the COVID-19 pandemic.

Furthermore, with the escalating number of accidents, the implementation of biomimetics for orthopedics is projected to boom. According to Association for Safe International Road Travel, every year about 20 to 50 million people worldwide suffer from injuries that leads to permanent disability. Hence, such factors are estimated to impact positively the growth of the medical biomimetics market.

On the other hand, a stringent regulatory framework hinders the medical biomimetics industry's growth. Regarding the ever-increasing and widespread applications of biomimetic biomaterials in numerous medical fields, their precise assessment is of great significance. Although each biomaterial undergoes thorough premarket evaluation, the regulatory organizations receive a significant number of adverse event and complications reports each year. Moreover, biomaterials are integrated into biological systems, hence, they must fulfill all scientific requirements such as high biocompatibility, sufficiently long shelf-life, and accommodating biological interactions.

Request a free sample copy or view report summary: Medical Biomimetics Market Report

Medical Biomimetics Market Report Highlights

• By type, the cardiovascular segment held the largest share of the medical biomimetics market. This is attributed to the increasing research activities and rising cases of cardiovascular diseases which in turn is likely to increase the adoption of biomimetics and anticipate the medical biomimetics market growth
• The wound healing segment is expected to grow exponentially over the forecast period. The demand for wound healing and wound care products is growing owing to the escalating number of surgical cases and the increasing prevalence of chronic diseases globally
• The drug delivery segment of the medical biomimetics market is anticipated to grow at the fastest rate due to crucial developments in nanotechnology that have facilitated efficient and accurate non-carrier drug delivery using biomimetics based devices. Adequate funding and advancements in research and development will boost the medical biomimetics market growth
• North America dominated the global medical biomimetics market in 2021 due to the high R&D investment, development of novel products, and strong funding from the government in the region
• The Asia Pacific is expected to grow significantly in the future owing to the expansion of business by key market players along with the increasing prevalence of chronic disorders
• A few of the key medical biomimetics market players include Otsuka Medical Devices Group, Stryker, Abbott, AVINENT Science and Technology, SynTouch Inc, Osteopore International Pte Ltd, and others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-medical-biomimetics-market

Medical Biomimetics Market Segmentation

Grand View Research has segmented the global medical biomimetics market based on, type, application, and region:

Medical Biomimetics Type Outlook (Revenue, USD Million, 2018 - 2030)

• Cardiovascular
• Orthopedic
• Ophthalmology
• Dental
• Others

Medical Biomimetics Application Outlook (Revenue, USD Million, 2018 - 2030)

• Wound Healing
• Tissue Engineering
• Drug Delivery
• Other Applications

Medical Biomimetics Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players in Medical Biomimetics Market

• Otsuka Medical Devices Group
• Stryker
• Abbott
• AVINENT Science and Technology
• SynTouch Inc
• Osteopore International Pte Ltd
• Vandstrom, Inc.
• Biomimetics Technologies Inc
• Swedish Biomimetics 3000 ApS
• Keystone Dental Group
• LifeMatrix
• Curasan, Inc. 
• CorNeat Vision 
• NanoHive Medical LLC
• Zimmer Biomet

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Needle-free Injectors Market Growth in the Coming Years

 Needle-free Injectors Market Growth & Trends 

The global needle-free injectors market size is expected to reach USD 2.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.8% from 2022 to 2030. Increasing prevalence of chronic diseases and rising patient volume are factors projected to enhance the demand for needle-free injectors. 

As a result of a sedentary lifestyle, the prevalence of lifestyle-associated diseases such as diabetes and hypertension is expected to increase during the forecast period. These diseases demand round-the-clock monitoring of various physiological parameters such as blood pressure and blood sugar levels. This allows integration of healthcare data with portable devices such as needle-free injectors and further this can be forwarded to physicians or doctors in order to have real-time access to data and reduce errors, thereby expected to propel the demand for needle-free injectors. 

The global needle-free injectors market is expected to witness lucrative growth owing to growing geriatric population coupled with rise in prevalence of chronic diseases such as cancer, diabetes, neurological disorders, hypertension, and age-related orthopedic disorders. In addition, increasing awareness, coupled with rise in adoption of needle-free injectors, is expected to promote market growth. 

Constant rise in geriatric population base is aggregating the financial demands on the health care system. According to the Population Reference Bureau, the number of Americans aged 65 and above is predicted to nearly double from 52 million in 2018 to 95 million by 2060. Such rise in elderly population base will subsequently result in greater demand for needle-free injectors, hence predicting to enhance the market progression. 

Request a free sample copy or view report summary: Needle-free Injectors Market Report

Needle-free Injectors Market Report Highlights

• The powder-based needle-free injectors segment held the largest market share in 2022 owing to the rising demand for these injectors among individuals
• The disposable segment held significant market share in 2022 due to the ease of use and presence of a built-in glass syringe that minimizes the need to manually load the glass syringe, ultimately making it convenient for patients
• The pain management segment is anticipated to gain the highest market share during the forecast period due to the increasing number of pain-related cases all across the globe
• North America is the leading market in 2022 owing to favorable regulatory reimbursement and growing demand for needle-free injectors
• Asia Pacific is expected to witness the fastest growth rate during the forecast period due to the availability of low-cost labor for manufacturing across several countries of Asia 

Access Press Release@ https://www.grandviewresearch.com/press-release/global-needle-free-injectors-market

Needle-free Injectors Market Segmentation

Grand View Research has segmented the global needle-free injectors market on the basis of product, type, technology, delivery site, usability, application, end-use, and region: 

Needle-free Injectors Product Outlook (Revenue, USD Million, 2018 - 2030)

• Fillable
• Prefilled

Needle-free Injectors Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Spring-based Needle-free Injector
• Gas-powered Needle-free Injector
• Laser-powered Needle-free Injectors
• Vibration-based Needle-free Injectors

Needle-free Injectors Usability Outlook (Revenue, USD Million, 2018 - 2030)

• Disposable
• Reusable

Needle-free Injectors Type Outlook (Revenue, USD Million, 2018 - 2030)

• Powder-based Needle Free Injectors
• Liquid-based Needle Free Injectors
• Projectile/depot-based Needle Free Injectors

Needle-free Injectors Application Outlook (Revenue, USD Million, 2018 - 2030)

• Vaccine Delivery
• Insulin Delivery
• Pain Management
• Others

Needle-free Injectors Delivery Site Outlook (Revenue, USD Million, 2018 - 2030)

• Subcutaneous
• Intramuscular
• Intradermal

Needle-free Injectors End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics
• Home Care Settings
• Research Laboratories

Needle-free Injectors Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Needle-free Injectors Market

• PharmaJet
• Crossject
• Portal Instruments
• NuGen Medical Devices
• Inovio Pharmaceuticals
• Antares Pharma, Inc
• Aijex Pharma International Inc.
• Ferring B.V.
• Penjet Corporation
• Medical International Technology Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.